Immuneering Corp (IMRX) SEC Filings — 2025
12 SEC filings for Immuneering Corp (IMRX) in 2025.
Filings
- Immuneering's Cash Soars to $227M Amid Widening Losses — 10-Q · Nov 12, 2025
- Immuneering Corp. Signs Material Definitive Agreement — 8-K · Sep 25, 2025
- Immuneering Corp Files 8-K: Material Agreement & Equity Sales — 8-K · Sep 24, 2025
- Immuneering Corp. Reports Material Definitive Agreement — 8-K · Aug 25, 2025
- Immuneering's Cash Dwindles Amid Widening Losses, Going Concern Doubts — 10-Q · Aug 13, 2025
- Pfizer to Acquire Immuneering for $625M — 8-K · Jun 17, 2025
- Immuneering Corp. Files 8-K on Shareholder Vote Matters — 8-K · Jun 16, 2025
- Immuneering Corp Files Q1 2025 10-Q — 10-Q · May 5, 2025
- Immuneering Corp Files 2025 Proxy Statement — DEF 14A · Apr 21, 2025
- Immuneering Corp 10-K Filing — 10-K · Mar 20, 2025
- Pfizer to Acquire Immuneering Corp. — 8-K · Jan 13, 2025
- Pfizer to Acquire Immuneering Corp for $635M — 8-K · Jan 7, 2025